The trigemino-vascular system and migraine.

Pathol Biol (Paris). 1992 Apr;40(4):313-7.
Links
The trigemino-vascular system and migraine.
Buzzi MG, Moskowitz MA.
I Clinica Neurologica, Dipartimento di Scienze Neurologiche, Università degli Studi La Sapienza, Rome, Italy.
Neurogenic inflammation has been proposed as a possible pathogenetic mechanism for migraine and cluster headache. Antidromic stimulation of trigeminal fibers causes plasma protein extravasation, mast cell activation and degranulation, vacuolation and increase in endothelial vesicle number within post capillary venules in rat dura mater. The antimigraine drugs sumatriptan and dihydroergotamine block the development of plasma extravasation and ultrastructural changes, as well as plasma calcitonin gene-related peptide (CGRP) increase in the superior sagittal sinus following electrical trigeminal ganglion stimulation. Sumatriptan and dihydroergotamine bind with high affinity to the 5-HT1D/1B receptors, thus suggesting that their neurogenic antiinflammatory activity is mediated by activation of 5-HT autoreceptors present on sensory fibers innervating blood vessels in dura mater.
PMID: 1379707 [PubMed - indexed for MEDLINE]
Related articles
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
Cephalalgia. 1991 Sep; 11(4):165-8.
[Cephalalgia. 1991]
ReviewNeurogenic inflammation in the context of migraine.
Microsc Res Tech. 2001 May 1; 53(3):167-78.
[Microsc Res Tech. 2001]
5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation.
Brain Res. 1992 Jun 26; 583(1-2):137-49.
[Brain Res. 1992]
Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Neuropeptides. 1999 Feb; 33(1):41-6.
[Neuropeptides. 1999]
ReviewRationale for the use of 5-HT1-like agonists in the treatment of migraine.
J Neurol. 1991; 238 Suppl 1:S57-61.
[J Neurol. 1991]
» See reviews... » See all...